2-(4-METHYLPHENYL)-1,2-BENZISOTHIAZOL-3(2H)-ONE, 95.0%, 250mg

(2R,4R)-4-(tert-Butoxy)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid, 98%, 1g

2,2,2-trifluoro-1-(2-hydroxy-3,3-dimethylcyclopent-1-en-1-yl)ethan-1-one, 95%, 50mg

1-(1-Hexyl)-piperazine, 98.0%, 5g

1-(Propane-1-sulfonyl)piperazine hydrochloride, 95%, 5g

tert-Butyl (4-bromo-5-formylthiazol-2-yl)carbamate, 95.0%, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.35 µm, 1 Piece(s)

4-(2,4-dichlorophenyl)-3-methyl-1H-pyrazol-5-amine hydrochloride, 95.0%, 500mg

TRIS(2,2,2-TRIFLUOROETHYL)PHOSPHITE, 95.0%, 1g

ASTEMIZOLE, 95%, 250mg

5-Decyne, 98.0%, 25g

ETHYL 5-FORMYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLATE, 95%, 250mg

1-(3,4-Dihydroxyphenyl)propan-2-one, 95.0%, 25mg